Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ustekinumab in adolescents with recent-onset type 1 diabetes
ISRCTN14274380Phase 2Completed
- Sponsor
- Cardiff University
- Start
- Dec 2018
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
01
Overview
Phase 2, randomised trial in diabetes mellitus type 1 (T1D) comparing Ustekinumab with Placebo (2 arms). Primary endpoint: Stimulated 2-hour insulin C-peptide area under the curve. Started Dec 2018; status: completed.
02
Drugs
ustekinumab
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on ISRCTN14274380.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN14274380.